High Immunoexpression of COX-2 as a Metastatic Risk Factor in ccRCC without PD-L1 Involvement

High Immunoexpression of COX-2 as a Metastatic Risk Factor in ccRCC without PD-L1 Involvement

Sri Suryanti, Hasrayati Agustina, Afiati Aziz, Herry Yulianti, Bethy Suryawathy, Lestari Putri Department of Anatomical Pathology, Faculty of Medicine, Universitas Padjadjaran/Dr. Hasan Sadikin Hospital, Bandung, IndonesiaCorrespondence: Lestari PutriDepartment of Anatomical Pathology, Faculty of Me...

Full description

Bibliographic Details
Main Authors:	Suryanti S, Agustina H, Aziz A, Yulianti H, Suryawathy B, Putri L
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-08-01
Series:	Research and Reports in Urology
Subjects:	clear cell renal cell carcinoma cyclooxygenase-2 metastasis programmed death ligand-1
Online Access:	https://www.dovepress.com/high-immunoexpression-of-cox-2-as-a-metastatic-risk-factor-in-ccrcc-wi-peer-reviewed-fulltext-article-RRU

Similar Items

Integrative Analysis of DNA Methylation Identified 12 Signature Genes Specific to Metastatic ccRCC
by: Siwei Qian, et al.
Published: (2020-10-01)

Expression of micro-RNAs and genes related to angiogenesis in ccRCC and associations with tumor characteristics
by: Rita de Cássia Oliveira, et al.
Published: (2017-12-01)

Prognostic role of PHYH for overall survival (OS) in clear cell renal cell carcinoma (ccRCC)
by: Qiu Zhengqi, et al.
Published: (2021-01-01)

Integrating regulatory and methylome data for the discovery of clear cell Renal Cell Carcinoma (ccRCC) variants
by: Calvert-Joshua, Tracey
Published: (2016)

In-Depth Mapping of the Urinary <i>N</i>-Glycoproteome: Distinct Signatures of ccRCC-related Progression
by: Lucia Santorelli, et al.
Published: (2020-01-01)

Characterization of the Prognostic Values of the CXCR1-7 in Clear Cell Renal Cell Carcinoma (ccRCC) Microenvironment
by: Zhulin Wu, et al.
Published: (2020-11-01)

KIF4A Promotes Clear Cell Renal Cell Carcinoma (ccRCC) Proliferation in vitro and in vivo
by: Yang GH, et al.
Published: (2020-03-01)

The Uniqueness of Clear Cell Renal Cell Carcinoma: Summary of the Process and Abnormality of Glucose Metabolism and Lipid Metabolism in ccRCC
by: Xiaochen Qi, et al.
Published: (2021-09-01)

Let-7i-5p enhances cell proliferation, migration and invasion of ccRCC by targeting HABP4
by: Yujie Liu, et al.
Published: (2021-03-01)

The immune‐related biomarker TEK inhibits the development of clear cell renal cell carcinoma (ccRCC) by regulating AKT phosphorylation
by: Siming Chen, et al.
Published: (2021-02-01)

Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data
by: Jiang-hui Zeng, et al.
Published: (2019-08-01)

GNRH1 and LTB4R might be novel immune-related prognostic biomarkers in clear cell renal cell carcinoma (ccRCC)
by: Hua-Hui Wu, et al.
Published: (2021-07-01)

SDHB Suppresses the Tumorigenesis and Development of ccRCC by Inhibiting Glycolysis
by: Zhiyu Fang, et al.
Published: (2021-05-01)

Silencing of the chemokine CXC receptor 4 (CXCR4) hampers cancer progression and increases cisplatin (DDP)-sensitivity in clear cell renal cell carcinoma (ccRCC)
by: Wenguang Wang, et al.
Published: (2021-01-01)

Co-expression network analysis identified six hub genes in association with progression and prognosis in human clear cell renal cell carcinoma (ccRCC)
by: Lushun Yuan, et al.
Published: (2017-12-01)

CTLA4 has a profound impact on the landscape of tumor-infiltrating lymphocytes with a high prognosis value in clear cell renal cell carcinoma (ccRCC)
by: Shiyi Liu, et al.
Published: (2020-10-01)

Differencial proteome of clear-cell renal cell carcinoma (ccRCC) tissues
by: Ana Júlia Vieira de Ribeiro, et al.
Published: (2013-01-01)

ACAT1 and Metabolism-Related Pathways Are Essential for the Progression of Clear Cell Renal Cell Carcinoma (ccRCC), as Determined by Co-expression Network Analysis
by: Liang Chen, et al.
Published: (2019-10-01)

Anti-CAIX BBζ CAR4/8 T cells exhibit superior efficacy in a ccRCC mouse model
by: Bonal, D.M, et al.
Published: (2022)

Identification of a Novel Immune-Related Prognostic Biomarker and Small-Molecule Drugs in Clear Cell Renal Cell Carcinoma (ccRCC) by a Merged Microarray-Acquired Dataset and TCGA Database
by: Guan-Fa Xiao, et al.
Published: (2020-08-01)

MiR-30 family deregulation in ccRCC
by: Gonçalo Outeiro Pinho
Published: (2021)

A Non-Invasive Scoring System to Differential Diagnosis of Clear Cell Renal Cell Carcinoma (ccRCC) From Renal Angiomyolipoma Without Visible Fat (RAML-wvf) Based on CT Features
by: Xiao-Jie Wang, et al.
Published: (2021-04-01)

Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy
by: Anna Reustle, et al.
Published: (2020-03-01)

Pivotal biomarker expression and drug screening in advanced ccRCC
by: Wen Xiao, et al.
Published: (2020-06-01)

Expression of RSK4, CD44 and MMP-9 is upregulated and positively correlated in metastatic ccRCC
by: Jing Ma, et al.
Published: (2020-03-01)

Liq_ccRCC: Identification of Clear Cell Renal Cell Carcinoma Based on the Integration of Clinical Liquid Indices
by: Jianhong Zhao, et al.
Published: (2021-01-01)

Identification of genes of prognostic value in the ccRCC microenvironment from TCGA database
by: Bangbei Wan, et al.
Published: (2020-04-01)

Comprehensive Profiling of Primary and Metastatic ccRCC Reveals a High Homology of the Metastases to a Subregion of the Primary Tumour
by: Paranita Ferronika, et al.
Published: (2019-06-01)

Evaluation of the immunoexpression of COX-1, COX-2 and p53 in Crohn's disease Avaliação da imunoexpressão de COX-1, COX-2 e p53 na doença de Crohn
by: Mônica Romero, et al.
Published: (2008-12-01)

Genomic Fabric Remodeling in Metastatic Clear Cell Renal Cell Carcinoma (ccRCC): A New Paradigm and Proposal for a Personalized Gene Therapy Approach
by: Dumitru A. Iacobas, et al.
Published: (2020-12-01)

LRG1 May Accelerate the Progression of ccRCC via the TGF-β Pathway
by: Quan Hong, et al.
Published: (2020-01-01)

Transcription Factor and miRNA Interplays Can Manifest the Survival of ccRCC Patients
by: Shijie Qin, et al.
Published: (2019-10-01)

Immunoexpression of cyclooxygenase-1 and -2 in ulcerative colitis
by: A.P.R. Paiotti, et al.
Published: (2007-07-01)

Identification of metabolic genes essential for proliferation of clear cell Renal Cell Carcinoma (ccRCC) cells
by: Miess, H.
Published: (2015)

HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism
by: Weinan Du, et al.
Published: (2017-11-01)

Transcriptional Profiling Reveals Kidney Neutrophil Heterogeneity in Both Healthy People and ccRCC Patients
by: Yiliang Meng, et al.
Published: (2021-01-01)

NF-κB and pSTAT3 synergistically drive G6PD overexpression and facilitate sensitivity to G6PD inhibition in ccRCC
by: Qiao Zhang, et al.
Published: (2020-10-01)

The study of transcriptome differentiation in VHL knockout model and specific genomic variations in Taiwanese ccRCC population
by: Chun-Liang Hsu, et al.
Published: (2019)

Tumor Microenvironment Features as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors (ICI) in Metastatic Clear Cell Renal Cell Carcinoma (mccRCC)
by: Audrey Simonaggio, et al.
Published: (2021-01-01)

Prognostic value of Cox-2 and PD-L1 expression and its relationship with tumor-infiltrating lymphocytes in resected lung adenocarcinoma
by: Shimizu K, et al.
Published: (2017-11-01)